SinoMab BioScience (3681.HK) Earnings Analysis
SinoMab BioScience (3681.HK) next reports earnings on 2026-08-24. Trailing P/E -11.88.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 3681.HK next report earnings?
| Next earnings date | 2026-08-24 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
3681.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-03-31 | -0.09346 HKD | n/a | n/a | n/a |
| 2024-08-19 | -0.09083 HKD | n/a | n/a | n/a |
3681.HK valuation and analyst view
| Trailing P/E | -11.88 |
|---|---|
| Trailing EPS | -0.07592 HKD |
| Price / book | 2.72 |
| Dividend yield | 0.00% |
| Market cap | 1.34B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is SinoMab BioScience (3681.HK)'s next earnings date?
SinoMab BioScience is next scheduled to report on 2026-08-24.
Did 3681.HK beat earnings last quarter?
Consensus estimate data was not available for 3681.HK's 2025-03-31 report.
What is 3681.HK's current P/E ratio and EPS?
3681.HK trades at a trailing P/E of -11.88 on trailing EPS of -0.07591706069181507 HKD.
What do analysts rate 3681.HK?
3681.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.